secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001860742-25-000021
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q3 revenue $1.28B (+7% YoY); narrows FY adjusted EBITDA guidance to $870M-$910M
--------------------------------------------------------------------------------

- Revenue $1.281B, up 7% reported (6% constant currency); Vision Care +8%, Surgical +4%, Pharmaceuticals +8%.
- GAAP net loss $28M ($0.08 loss per share) vs net income $4M ($0.01 EPS) in Q3 2024.
- Adjusted EBITDA excluding acquired IPR&D $243M, up from $227M; adjusted EPS excl. IPR&D $0.18 vs $0.17.
- FY 2025 revenue guidance reaffirmed at $5.05B-$5.15B; adjusted EBITDA guidance low end raised $10M to $870M-$910M.
- Cash from operations $137M vs $154M; CEO cites pipeline and investor day as upcoming catalysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074225000021/0001860742-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074225000021/blco-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001860742-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer